Managing Directors
Advisory Board

Grant Colby, MBA

Grant Colby, MBA

Managing Director & CEO

250-661-2050 | email: gcolby@ncpim.com

  • Former CEO & Portfolio Manager of Galileo Global Equity Advisors
  • Founding partner & lead private equity manager of Northland Bancorp
  • Multifamily Office portfolio manager with more than 25 years experience
Mario Jacob, LLB, ASC

Mario Jacob, LLB, ASC

Managing Director & Counsel

418-653-9339 | email: mjacob@ncpim.com

  • President of Maximus Capital Inc.
  • 15 years of corporate finance, and mergers & advisory experience
  • Lawyer and member of the Quebec Bar since 1995
  • Chartered Director from College des Administrateurs de Sociétés
Christian Gagnon, MBA, Eng

Christian Gagnon, MBA, Eng

Managing Director & CIO

514-402-4052 | email: cgagnon@ncpim.com

  • Former partner of hedge fund manager AFC Capital
  • Lead manager of mining & materials segment
  • 15 years as private &/or public equity portfolio manager
  • 5 years as mining project engineer for Cambior (Iamgold)
Alex Rothwell, MBA, Eng

Alex Rothwell, MBA, Eng

Strategic Advisor
  • Former President and Head of Equities Macquaire Capital Markets Canada.
  • Prior to that, Senior Managing Partner and Head of Institutional Sales at Orion Securities, a partner-owned investment bank that was owned by Macquarie in 2007.
  • Began investment career in 1995 as M&A arbitrage advisor to US Hedge funds with Bunting Warburg, which was later acquired by UBS Canada.
  • Deep knowledge of, and connections to, a global network of institutional investors who are active in Canadian equities.
Dr. Huaizheng Peng, Ph.D, M.Med, MD

Dr. Huaizheng Peng, Ph.D, M.Med, MD

Strategic Advisor
  • Dr. Huaizheng Peng is a Director of the Board and General Manager International Operations for China Medical System Holdings.
  • Prior to that, he was a director of corporate finance and head of life sciences at Seymour Pierce, a leading London-based investment bank.
  • From 1999 to 2007, Dr. Peng was a senior portfolio manager, specializing in global life science and Asian technology investment in Reabourne Technology Investment Management Company (now part of Close Brothers Asset Management Company).
  • Bachelor (84) and Masters (89) of Medicine from Hunan Medical University in Changsha, Hunan, Master of Medicine. PhD in Molecular Pathology from University College London (UCL) Medical School, London, UK, in 1998 and practiced as a clinical lecturer at the UCL Medical School, London, UK.